An apoptotic signal triggered by cell surface death receptors is disseminated to intracellular compartments through protein-protein interactions mediated by conserved domains such as the death effector domain (DED). A unique family of single DED-containing proteins, including DEDD and DEDD2, is targeted to the nucleolus. However, the role of DEDD/DEDD2 in apoptosis remains less understood. Here we show that DEDD and DEDD2 are highly conserved in diverse species, and that they are potent inducers of apoptosis in various cell types. Deletion analysis indicates that both the N-terminal DED domain and the C-terminal region of DEDD2 can induce apoptosis. The cell death activity of this family appears to be related to their nuclear localization. DEDD and DEDD2 bind to two tandem DED-containing caspases, caspase -8 and -10, that are engaged by death receptors. Consistent with the nuclear localization of this family, caspase-8 translocates to the nucleus during CD95-induced apoptosis. DEDD and DEDD2 also readily associate with themselves and with each other. These results suggest that DEDD and DEDD2 may be important mediators for death receptors and that they may target caspases to the nucleus. Oncogene ( Keywords: DEDD; DEDD2; caspase-8/10; apoptosis Apoptosis plays critical roles in development, maintenance of homeostasis, and protection against cancer. Death receptors in the tumor necrosis factor receptor (TNFR) superfamily -which include TNFR1 (p55/ CD120a), CD95 (Fas/APO-1), death receptor 3 (DR3, Apo3/WSL-lATRAMP/LARD), DR4, and DR5 (Apo2fTRAIL-R2/KILLER/TRICK 2) -are important mediators of mammalian cell death (Ashkenazi and Dixit, 1998) . Over the past several years, the molecular events underlying death-receptor-mediated apoptosis have begun to be unraveled (Ashkenazi and Dixit, 1998) . Upon binding to their cognate ligands or agonistic antibodies, death receptors such as CD95 become associated with a cellular adapter protein FADD/MORT via homophilic interaction involving a conserved motif, termed the death domain, that are present in both proteins. FADD contains another conserved domain known as the death effector domain (DED), which recruits two tandem DED-containing caspases -procaspase-8 and procaspase-10 -to the receptors through homophilic DED-DED interactions. Oligomerization of procaspase-8 (and probably caspase-10) in this membrane-bound signaling complex leads to their autoproteolytic activation (Martin et al., 1998; Muzio et al., 1998; Yang et al., 1998a) . A DED domain is also present in a nucleolus-targeted protein DEDD (Stegh et al., 1998) . Upon its overexpression or during CD95-mediated apoptosis, DEDD translocates to the nucleus, where it may interfere with the synthesis of rRNA (Stegh et al., 1998; Schickling et al., 2001) . Recently, a human DEDD homologue known as DEDD2 or FLAME-3 was identified (Roth et al., 2002; Zhan et al., 2002) . However, to date only weak proapoptosis activity has been attributed to this family of DED-containing proteins. Whether DEDD and DEDD2 play a significant role in apoptosis induction and if so, how they may induce apoptosis remain largely unknown.
Apoptosis plays critical roles in development, maintenance of homeostasis, and protection against cancer. Death receptors in the tumor necrosis factor receptor (TNFR) superfamily -which include TNFR1 (p55/ CD120a), CD95 (Fas/APO-1), death receptor 3 (DR3, Apo3/WSL-lATRAMP/LARD), DR4, and DR5 (Apo2fTRAIL-R2/KILLER/TRICK 2) -are important mediators of mammalian cell death (Ashkenazi and Dixit, 1998) . Over the past several years, the molecular events underlying death-receptor-mediated apoptosis have begun to be unraveled (Ashkenazi and Dixit, 1998) . Upon binding to their cognate ligands or agonistic antibodies, death receptors such as CD95 become associated with a cellular adapter protein FADD/MORT via homophilic interaction involving a conserved motif, termed the death domain, that are present in both proteins. FADD contains another conserved domain known as the death effector domain (DED), which recruits two tandem DED-containing caspases -procaspase-8 and procaspase-10 -to the receptors through homophilic DED-DED interactions. Oligomerization of procaspase-8 (and probably caspase-10) in this membrane-bound signaling complex leads to their autoproteolytic activation (Martin et al., 1998; Muzio et al., 1998; Yang et al., 1998a) . A DED domain is also present in a nucleolus-targeted protein DEDD (Stegh et al., 1998) . Upon its overexpression or during CD95-mediated apoptosis, DEDD translocates to the nucleus, where it may interfere with the synthesis of rRNA (Stegh et al., 1998; Schickling et al., 2001) . Recently, a human DEDD homologue known as DEDD2 or FLAME-3 was identified (Roth et al., 2002; Zhan et al., 2002) . However, to date only weak proapoptosis activity has been attributed to this family of DED-containing proteins. Whether DEDD and DEDD2 play a significant role in apoptosis induction and if so, how they may induce apoptosis remain largely unknown.
In an effort to study the function of DEDD in apoptosis, we isolated a human and a mouse protein that share identity with DEDD throughout their lengths, and were subsequently found to be the same as the recently reported human and mouse DEDD2/ FLAME-3, respectively. Interestingly, partial protein sequences remarkably homologous to human DEDD (with 91% or higher identity) were found in various species including chicken and xenopus ( Figure 1a) . Homologues of human DEDD2 also exist in other organisms including zebrafish and xenopus (with 44% or higher identity) (Figure 1a) . The evolutionary conservation of DEDD and DEDD2 suggests that this family of proteins may play an important role in cellular functions.
DEDD2 is expressed in various human tissues as a 2.0-kb major transcript and a 1.8-kb minor transcript (Roth et al., 2002, Zhan et al., 2002, and Figure 1b) . To determine the expression profile of DEDD2 in various tumor cells, a human multiple cancer cell line Northern blot was hybridized with a human DEDD2 cDNA probe. The expression level of DEDD2 is relatively high in the chronic myologenous leukemia K-562 and the colorectal adenocarcinoma SW480 but moderate in the cervical carcinoma HeLa, the Burkitt's lymphoma Raji, the lung carcinoma A549, and the melonoma G361. In contrast, two leukemia cell lines, HL-60 (promyelocytic leukemia) and MOLT-4 (lymphoblastic leukemia), show relatively low levels of DEDD2 expression (Figure 1b) . The human DEDD2 gene was mapped to chromosome 19ql3.2, and abnormalities in this region are frequently found in various tumors. Mouse DEDD2, on the other hand, is expressed as a 2.0-transcript (Figure 1b) . The expression level of mouse DEDD2 is high in liver, heart, kidney, and testis but low in brain, spleen, lung, and skeleton muscle, and this pattern of expression does not mirror that of human DEDD2.
Overexpression of certain DED-containing proteins such as FADD and caspase-8 leads to robust apoptosis in mammalian cells. The proapoptotic activity of DEDD/DEDD2 was previously examined by using a cotransfected reporter gene to label the DEDD/ DEDD2-expressing cells (Stegh et al., 1998; Roth et al., 2002; Zhan et al., 2002) . Using a similar approach, we also only detected minimal apoptosis activity of DEDD/ DEDD2 (data not shown). However, because both DEDD and DEDD2 translocate to the nucleolus upon overexpression and are likely to inhibit protein synthesis (Stegh et al., 1998; Roth et al., 2002; Zhan et al., 2002 , and see below), high levels of the reporter gene expression in transfected cells may very well indicate weak expression of DEDD/DEDD2 and vice versa. Thus, using a fusion protein instead of a cotransfected reporter was deemed important to accurately reflect the expression levels of DEDD2/DEDD. Green fluorescence protein (GFP) fusions of DEDD and DEDD2 were transiently transfected into HeLa cells, and cell death was scored among GFP positive cells based on the morphological changes typical of adherent cells undergoing apoptosis such as rounded cell shape, membrane blebbing, detachment from plates, and refractory appearance. Both proteins induced specific apoptosis in over 60% of the transfected cells ( Figure 2b ). These levels of apoptosis were comparable to that stimulated by FADD under the same conditions (Figure 2b ), suggesting that both DEDD and DEDD2 are potent apoptosis inducers. To ensure that DEDD/DEDD2-induced apoptosis was not peculiar to HeLa cells, we also examined the effects of DEDD and DEDD2 overexpression on human 293, green monkey COS-1, and mouse fibroblast 3T3 cells. As was seen in HeLa cells, DEDD and DEDD2 showed similar proapoptotic activities as FADD in these cells (Figure 1c-e) .
DEDD2, like DEDD, contains an NH 2 -terminal region with the DED domain and a COOH-terminal region homologous to certain DNA-binding proteins such as histones (Stegh et al., 1998; Roth et al., 2002) . To delineate the effector domain of DEDD2, GFP fusions of each of these regions (GFP-DEDD2-N1 and -C) were introduced into HeLa cells and 3T3 cells. Interestingly, both regions induced high levels of apoptosis (Figure 2b ,c). DEDD2 also contains three putative nuclear localization signals (Roth et al., 2002; Zhan et al., 2002) . To study a possible correlation between the cellular localization of DEDD2 and its proapoptosis activity, we examined the localization of the full-length and the deletion mutants of DEDD2. Consistent with previous reports and with the localization of DEDD, GFP-DEDD2 was found predominantly in the nucleolus colocalizing with UBF (upstream binding factor), a nucleolus-specific protein (Figure 3a) . Similarly, GFP-DEDD2-C was also found in the nucleolus. GFP-DEDD2-N1, on the other hand, appeared to be both cytosolic and nuclear, and was notably excluded from the nucleolus (Figure 3a) , suggesting that the COOH-but not the NH 2 -terminal region targets DEDD2 to the nucleolus. To assess whether the putative nuclear localization signal in DEDD2-N1 is required for its cytotoxicity, the signal was deleted and the resulting fusion, GFP-DEDD2-N2, was able to kill cells with slightly reduced efficiency compared with GFP-DEDD-N1 (Figure 2b, c) . This region, however, still resided in the nucleus (Figure 1a) , which was possibly mediated by a cellular factor(s). To further determine whether nuclear localization is critical for DEDD/DEDD2-mediated apoptosis, we mutated all previously identified nuclear localization signals on each of these proteins. The resulting DEDD mutant (GFP-DEDDDNLS) was almost exclusively cytosolic, consistent with previous reports (Schickling et al., 2001) , whereas the GFP-DEDD2DNLS mutant was present in both the cytosolic and the nuclear compartments (Figure 3b ). In the apoptosis assay, the former failed to kill cells while the latter retained substantial cell death activity (Figure 2f ). Taken together, these results suggest that the DEDD/DEDD2's proapoptotic activity is related to their nuclear localization.
To examine whether the proapoptotic effect of DEDD/DEDD2 is mediated by caspases, we cotransfected them with crmA, a serpin caspase inhibitor that directly targets the active sites of caspases, particularly those of caspase-1 and -8 (Chang and Yang, 2000) . As shown in Figure 2g , DEDD-and DEDD2-induced apoptosis was inhibited by crmA. Additionally, it was noted that in the presence of crmA, both the number of cells expressing the GFP-DEDD/DEDD2 protein and 3 Figure 1 Interspecies conservation of DEDD and DEDD2. (a) Comparison of DEDD and DEDD2 proteins from various species. Sequence alignment and homology evaluation were performed using the Mac Vector software (CLUSTAL). The zebrafish DEDD2 shown is the full-length protein sequence while the xenopus and chicken DEDD and the xenopus DEDD2 are partial sequences. Aminoacid residue numbers are given to the right of the sequence. Dotted lines indicate unidentified sequences and dots are inserted gaps for optimal alignment. Identical residues are boxed. (b) Expression profile of human and mouse DEDD2 mRNA. A human multiple tumor cell line mRNA blot (left) and a human and a mouse multiple tissue mRNA blots (middle and right, respectively) were hybridized with a radioisotope-labeled DEDD2 cDNA probe from the same species according to the manufacturer's instruction (Clontech). The sources of the mRNA are indicated above. Expression of b-actin is shown below as a loading control and size markers are indicated. SI: small intestine. BL: blood leukocyte the expression levels of GFP-DEDD/DEDD2 were greatly enhanced (data not shown). Therefore, DEDD/ DEDD2-induced apoptosis is dependent on caspase activation.
Given that the DED domain mediates homophilic interactions and the possible involvement of caspase in DEDD/DEDD2-mediated apoptosis, we examined whether DEDD2 interacts with the two tandem DEDcontaining caspases, caspase-8 and -10, using a mammalian cell immunoprecipitation assay. Hemagglutinin (HA)-tagged DEDD2 together with FLAG-tagged caspase-8 or -10 were transiently expressed in human 293 cells and the cell lysates were immunoprecipitated with an anti-FLAG antibody. This assay revealed that DEDD2 interacted specifically with both caspase-8 and -10 ( Figure 4a, lanes 2, 3) . The interaction was mediated by the N-terminal region of DEDD2 that encompassed mainly the DED domain (Figure 4a, lane 5) . Similarly, DEDD also associated with both caspases, but no interaction between DEDD/DEDD2 and FADD was detected (data not shown). Thus, DEDD and DEDD2 may engage both caspase-8 and -10 to deliver the lethal stimulus to the nucleus.
We also found that DEDD and DEDD2 can readily associate with themselves and with each other (Figure 4b, lane 2, 3) , and both the N-terminal DED (Figure 4b, lanes 4, 5) . The latter was confirmed by the GST pull-down assay using recombinant GST-DEDD2-N1 and -C and in vitro translated, [
35 S]methionine-labeled DEDD and DEDD2 (Figure 4c ). Activation of initiator caspases such as caspase-8 is triggered by adapter-mediated oligomerization (Chang and Yang, 2000) . Thus, it is possible that DEDD and DEDD2 may promote activation of caspase-8/10 through their ability to bind to caspase-8/10 as well as their ability to self-oligomerize.
Caspase-8 is a cytosolic protein in living cells. If DEDD/DEDD2 is to target caspase-8 to the nucleus, then caspase-8 is expected to be found in the nucleus at the early stage of CD95-mediated apoptosis. To test this possibility, HeLa cells were treated with agonistic anti-CD95 antibody. The cell lysates were fractionated into the cytosolic and nuclear fractions. Interestingly, in the presence but not in the absence of CD95 stimulation, both partially processed and mature caspase-8 molecules were found in the nucleus. The former contains the DED domains and should retain the ability to interact with DEDD/DEDD2. The translocation of caspase-8 occurred before detectable apoptosis and caspase-3 activation. The specificity of the fractionation procedures was confirmed by the detection of b-tubulin, a cytosolic protein, and PML, a protein found mainly in the nucleus, in the expected fractions. Additionally, the translocation was dependent on caspase activation because it was inhibited by a caspase inhibitor zVADfmk.
In summary, we show that DEDD and DEDD2 are conserved through evolution and they are strong inducers of apoptosis. The function of DEDD/DEDD2 in apoptosis is unique in that they are targeted to the nucleolus, a subnuclear structure critical for the regulation of protein synthesis. Inhibition of protein synthesis was shown to be an early event upon Fas engagement (Zhou et al., 1998) . Given that DEDD/DEDD2 interacts with both caspase-8 and -10, they may target these interacts with caspase-8 and -10. Expression plasmids for HA-DEDD2 and HA-DEDD2-N1 were transfected into 293 cells together with the vector control, FLAG-caspase-8, or FLAG-caspase-10 as indicated. Cell lysates were made in IP-lysis buffer (Yang et al., 1998b) and incubated with anti-FLAG M2 beads conjugated on agarose beads (Sigma). The anti-FLAG immunoprecipitates (IP) and extracts were subjected to Western blotting analysis (W) with rabbit anti-FLAG or anti-HA antibodies (Santa Cruz Biotech). Similar results were obtained for DEDD. Caspase-8/10 did not interact with the C-terminal region of DEDD2 (data not shown). (b) Homoand heteroassociation of DEDD2 and DEDD 293 cells were transfected with HA-DEDD2 (top two panels) or HA-DEDD (middle two panels) together with expression plasmids for the indicated FLAG-tagged proteins. Anti-FLAG IP and extracts were analysed by Western blotting using indicated antibodies. The bottom panel shows the representative relative levels of FLAG-tagged proteins in the anti-FLAGIP for both HA-DEDD2-and HA-DEDD-transfected cells. The data shown in (a) and (b) are representative of three independent experiments. (c) In vitro GST pull-down assay. DEDD2-N1 and DEDD2-C were cloned into pGEX-1lT (Amersham Pharmacia). DH5a transformants expressing the desired GST fusions were lysed and the insoluble pellet was dissolved in 1/50 volume 8m urea in 1 Â PBS, which was subsequently dialyzed stepwise to 1 Â PBS with decreasing concentration of urea to allow for protein renaturation. The resulting solution was subsequently incubated with glutathione-conjugated beads (Amersham Pharmacia). For in vitro binding experiments, 10 mg of each GST fusion immobilized on beads was incubated for 2 h with in vitro translated, [ 35 S]methionine proteins. The binding proteins were analysed by SDS-PAGE and autoradiography. The inputs represent 5% of the samples used for binding. (d) Translocation of caspase-8 during CD95-mediated apoptosis. HeLa cells were treated for 24 h with anti-CD95 mAb CH11 (MBL, 50 ng/ml) plus IFN-g (Roche, 5 ng/ml), in the presence or absence of caspase inhibitor z-VAD (ESP), or treated with IFN-g alone (cell death is o5%). The cell pellets were suspended in buffer A (10 mm Tris-HCl pH 8.0, 3 mm CaCl 2 , 2 mm MgCl 2 , and 0.32 m sucrose) plus 0.5% Nonidet P-40, and homogenized in douncer (Wheaton, loose pestle), followed by centrifugation at l000 g for 5 min. The supernatant was designated as the cytosolic fraction. The pellets were re-suspended in buffer A, and mixed with equal volume of buffer B (10 mm Tris-HCl, pH 8.0, 2 m sucrose, 5 mm Mg(Ac) 2 , and 0.1 mm EDTA). The mixture was layered onto the buffer B and centrifuged at 30 000 g for 45 min. The pellet was designated as the nuclear fraction. The cytosolic (C) and the nuclear (N) fractions were resolved on SDS-PAGE and analysed by immunoblotting using antibodies against indicated proteins. *A nonspecific band two caspases to the nucleolus to inhibit protein translation apparatus. Consistent with this possibility, caspase-8 was found to translocate to the nucleus during CD95-mediated apoptosis and the cell death activity of DEDD/DEDD2 is related to their nuclear localization. Furthermore, DEDD and DEDD2 form homo-and heterodimers and they could facilitate activation of caspase-8/10 through aggregation. These results suggest that DEDD and DEDD2 may play a critical role in death receptor-induced apoptosis.
